Salmedix, Inc.

Based in San Diego, CA, USA, Salmedix, Inc. was dedicated to creating value for patients and oncologists by developing unappreciated cancer drugs, with an initial commercial focus on hematologic cancers.

In June 2005, Cephalon, Inc. (Nasdaq: CEPH) completed its acquisition of Salmedix, Inc.